全文获取类型
收费全文 | 4808篇 |
免费 | 212篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 44篇 |
妇产科学 | 37篇 |
基础医学 | 481篇 |
口腔科学 | 131篇 |
临床医学 | 336篇 |
内科学 | 1295篇 |
皮肤病学 | 255篇 |
神经病学 | 414篇 |
特种医学 | 215篇 |
外科学 | 738篇 |
综合类 | 15篇 |
预防医学 | 141篇 |
眼科学 | 47篇 |
药学 | 409篇 |
中国医学 | 21篇 |
肿瘤学 | 433篇 |
出版年
2023年 | 25篇 |
2022年 | 74篇 |
2021年 | 108篇 |
2020年 | 68篇 |
2019年 | 72篇 |
2018年 | 102篇 |
2017年 | 92篇 |
2016年 | 100篇 |
2015年 | 89篇 |
2014年 | 120篇 |
2013年 | 130篇 |
2012年 | 272篇 |
2011年 | 280篇 |
2010年 | 155篇 |
2009年 | 132篇 |
2008年 | 251篇 |
2007年 | 248篇 |
2006年 | 222篇 |
2005年 | 201篇 |
2004年 | 226篇 |
2003年 | 188篇 |
2002年 | 198篇 |
2001年 | 140篇 |
2000年 | 144篇 |
1999年 | 117篇 |
1998年 | 43篇 |
1997年 | 45篇 |
1996年 | 42篇 |
1995年 | 35篇 |
1994年 | 39篇 |
1993年 | 38篇 |
1992年 | 103篇 |
1991年 | 81篇 |
1990年 | 67篇 |
1989年 | 86篇 |
1988年 | 80篇 |
1987年 | 57篇 |
1986年 | 65篇 |
1985年 | 68篇 |
1984年 | 51篇 |
1983年 | 36篇 |
1982年 | 21篇 |
1981年 | 22篇 |
1979年 | 36篇 |
1975年 | 25篇 |
1974年 | 23篇 |
1973年 | 24篇 |
1970年 | 22篇 |
1969年 | 21篇 |
1966年 | 20篇 |
排序方式: 共有5048条查询结果,搜索用时 15 毫秒
71.
Shiraishi H Ishibashi K Urao N Hyogo M Tsukamoto M Keira N Hirasaki S Seo Y Shirayama T Nakagawa M 《Internal medicine (Tokyo, Japan)》2002,41(6):445-448
Verapamil is widely used for the termination of paroxysmal supraventricular tachycardia (PSVT) with little proarrhythmic effect. We describe two cases of PSVT that changed to non-sustained polymorphic ventricular tachycardia after administration of verapamil. Electrophysiological study revealed atrioventricular nodal reentrant tachycardia in the first case, and atrioventricular reentrant tachycardia due to a concealed left lateral accessory pathway in the second case. Catecholamine-induced automaticity was one of the possible mechanisms of VT in the first case, but the mechanism is unknown in the second case. 相似文献
72.
Halgberg F Cornélissen G Watanabe Y Otsuka K Fiser B Siegelova J Mazankova V Maggioni C Sothern RB Katinas GS Syutkina EV Burioka N Schwrtzkopff O 《The journals of gerontology. Series A, Biological sciences and medical sciences》2001,56(5):M304-M324
Biological cycles with relatively long and some unusual periods in the range of the half-week, the half-year, years, or decades are being discovered. Their prior neglect constituted a confounder in aging and much other research, which then"flew blind" concerning the uncertainties associated with these cycles when they are not assessed. The resolution of more about 10-year and other cycles, some reported herein, replaces the admission of complete unpredictability, implied by using the label "secularity." Heretofore unaccounted-for variability becomes predictable insofar as it proves to be rhythmic and is mapped systematically to serve as a battery of useful reference values. About 10-year cycles in urinary 17-ketosteroid excretion and in heart rate and its variability, among others, are aligned with cycles of similar length in mortality from myocardial infarction. Associations accumulate between cycles of natural physical time structures, chronomes such as the 10.5-year (circadecennian) Schwabe and the 21-year (circavigintunennian) Hale cycles of solar activity, and chronomes in biota. There are about 50-year (circasemicentennian) cycles in mortality from stroke in Minnesota and in the Czech Republic and also in human morphology at birth, the latter result reducing the likelihood that these cycles are purely human made.Associations among large populations warrant long-term systematic coordinated sampling of natural physical and biological variables of interest for the design of countermeasures against already documented elevated risks of stroke, myocardial infarction, and other catastrophic diseases, notably in elderly adults. New findings will be introduced against the background of the documented value of mapping rhythms in medicine and gerontology. In both these fields, rhythms promise the seeming paradox of better care for less. 相似文献
73.
Aoki T Noma N Takajo I Yamaga J Otsuka M Yuchi H Ishikawa N Inatsu H Sakata J Asada Y Eto T 《Journal of gastroenterology》2002,37(3):204-209
99m Tc-labeled human serum albumin scintigram showing abnormal radioactivity in the stomach. Endoscopic gastric biopsies revealed
nonspecific inflammation, but marked intramural edema. Based on a slight elevation of antinuclear antibody level, autoimmune
disease was suspected to be involved in this patient. Administration of prednisolone, as a diagnostic therapy, alleviated
the hypoproteinemia, hypoalbuminemia, and hypercholesteremia. These findings suggest that an autoimmune mechanism could have
been involved in this case of protein-losing gastropathy.
Received: September 4, 2000 / Accepted: February 23, 2001 相似文献
74.
Sekijima Y Hashimoto T Koshihara H Kawachi Y Otsuka F Ikeda S 《Modern rheumatology / the Japan Rheumatism Association》2005,15(5):361-363
We report a patient with hereditary angioedema (HAE) presenting with skin edema and abdominal pain. Laboratory examination
showed reduced levels of CH50, C2, C4, and C1 inhibitor (C1-INH). Abdominal computed tomography (CT) showed marked mesenteric
edema and wall thickening of the duodenum and transverse colon. Acute abdominal pain is common in HAE and is difficult to
distinguish from surgical emergency. Massive mesenteric edema on CT is a rare, but specific, sign suggesting HAE. 相似文献
75.
Hiroaki Yoshikane Takio Yokoi Hitoshi Hidano Akira Sakakibara Yasumasa Niwa Hidemi Goto 《Journal of gastroenterology》1997,32(6):812-816
A 51-year-old man had a reddish flat granular lesion in the stomach on endoscopic examination. Histology of biopsied specimen confirmed the diagnosis of low-grade B-cell gastric lymphoma of mucosaassociated lymphoid tissue (gastric MALT lymphoma) and simultaneous infection withHelicobacter pylori. He was given antibiotic treatment. Five weeks later, endoscopy and histology of biopsied specimen showed eradication ofH. pylori, and the tumor had regressed. Six months later,H. pylori reemerged, but the tumor had not recurred. After the second antibiotic therapy,H. pylori has been eradicated. The lymphoma has been in remission for 14 months. 相似文献
76.
Katsuyoshi?Suzuki Naomi?Otsuka Hiroko?Hizaki Masayo?Hashimoto Yasuaki?Kuwayama On behalf of the Tafluprost/Timolol Versus Latanoprost/Timolol Study Group 《Advances in therapy》2018,35(6):796-808
Introduction
This was the first exploratory randomized controlled study to compare the efficacy and safety of a preserved tafluprost/timolol fixed combination (TAF/TIM) with a preserved latanoprost/timolol fixed combination (LAT/TIM).Methods
This prospective, randomized, open-label study was conducted in Japanese patients with primary open-angle glaucoma, including normal-tension glaucoma or ocular hypertension. Following a 4-week LAT/TIM run-in period, eligible patients entered a 12-week treatment period, during which they received either LAT/TIM or TAF/TIM. The efficacy endpoint was the change in intraocular pressure (IOP) from baseline to week 12 and the safety endpoints included the changes from baseline to week 12 in superficial punctate keratopathy (SPK) score, tear breakup time (TBUT), and hyperemia score, as well as adverse events (AEs). At week 6, ocular symptoms were evaluated using a questionnaire.Results
In total, 131 patients provided informed consent. Of these, 115 completed the run-in period and were assigned to receive TAF/TIM (n?=?60) or LAT/TIM (n?=?55). At week 12, there were no significant differences between the TAF/TIM and LAT/TIM groups in the change from baseline in trough IOP and IOP at 4–6 h after instillation. There were no significant differences between the two groups in the change from baseline to week 12 in SPK score, TBUT, and hyperemia score. However, only in the TAF/TIM group, the total SPK score and the inferior cornea SPK score were significantly lower at week 12 compared with baseline. Eye irritation and eye pain were significantly decreased in the TAF/TIM group compared with the LAT/TIM group. Two treatment-related AEs were reported in the TAF/TIM group (3.3%) and none in the LAT/TIM group, while no serious AEs were reported in either group.Conclusion
TAF/TIM is as effective as LAT/TIM in terms of IOP-reducing effect, with fewer ocular symptoms. TAF/TIM was associated with a significant improvement in SPK scores.Trial Registration
UMIN Clinical Trials Registry Identifier, UMIN000023862.Funding
Santen Pharmaceutical Co., Ltd., Osaka, Japan.77.
Yuka Yamada Ayako Wada Tomoyoshi Otsuka Kaori Muraoka Meigen Liu 《Disability and rehabilitation》2018,40(12):1421-1425
Purpose: Swallowing dysfunction has been reported in Duchenne muscular dystrophy (DMD), but has not been studied in Becker muscular dystrophy (BMD). The aims of this study were to report the characteristics of swallowing dysfunction in BMD compared with DMD.Materials and methods: The study participants were 18 patients with BMD and 18 patients with DMD. All the patients were examined using videofluorography during swallowing of 5?mL of fluid. The penetration–aspiration scale (P–A scale) and the videofluorographic dysphagia scale (VDS) were used to evaluate dysphagia.Results: Swinyard functional ability stage was not significantly different between the BMD and DMD groups. Rate of aspiration, P–A scale score, and total VDS score did not differ across groups, but the VDS item score for laryngeal elevation was lower in the BMD group than in the DMD group (median scores 4.5 and 9, respectively; p?0.001). In the BMD group, total VDS score significantly correlated with Swinyard stage (r?=?0.78, p?0.001), but not with age or lung function.Conclusion: Patients with BMD have swallowing problems similar to those observed in patients with DMD when matched according to physical functional status. These patients should be evaluated and followed-up for the duration of their disease.
- Implications for rehabiliation
Dysphagia is one of the most critical problems in patients with progressive neuromuscular disease but dysphagia in patients with Becker muscular dystrophy (BMD) was not well known.
Eighteen patients with BMD and 18 patients with Duchenne muscular dystrophy were examined with videofluorography.
Patients with BMD have swallowing problems similar to those observed in patients with DMD.
78.
79.
Toshihiro Miyamoto Masaki Iino Yasuji Komorizono Toru Kiguchi Nobufusa Furukawa Maki Otsuka Shohei Sawada Yutaka Okamoto Kenji Yamauchi Toshitaka Muto Tomoaki Fujisaki Hisashi Tsurumi Kimitoshi Nakamura 《Internal medicine (Tokyo, Japan)》2021,60(5):699
Objective For patients with Gaucher disease (GD), a rare, inherited lysosomal storage disease, obtaining a definitive diagnosis is currently time-consuming and costly. A simplified screening method to measure the glucocerebrosidase (GBA) activity using dried blood spots (DBS) on filter paper has recently been developed. Using this newly developed screening method, we evaluated real-world GD screening in patients suspected of having GD. Methods This multicenter, cross-sectional, observational study with a diagnostic intervention component evaluated real-world screening in patients suspected of having GD based on their clinical symptoms and a platelet count <120,000/μL. The endpoint was the number of patients with low GBA activity determined using DBS. Results In 994 patients who underwent initial DBS screening, 77 had low GBA activity. The assay was not repeated in 1 patient who was diagnosed as having a high possibility of GD due to clinical symptoms, and a further 21 patients completed the study without undergoing the second assay. Of the remaining 55 patients who had 2 DBS assays performed, 11 had a low GBA activity in both assays. Overall, DBS screening identified 12 (1.2%) patients with a low GBA activity, a proportion consistent with prior screening studies. Conclusion These results suggest that the simplified DBS method was less burdensome to patients, was easily utilized by many physicians, and could be a useful first-tier screening assay for GD prior to initiating burdensome genetic testing. 相似文献